Anti-angiogenetic Effect of Recombinant Human P43 and Its Mechanism

ZHOU Li-qiang,SUN Li,LIN Sen-sen,LIANG Wen-lu,LIU Da-tao,YUAN Sheng-tao,ZHU Dan-ni
2011-01-01
Abstract:The purpose of this study was to investigate the effects and mechanism of recombinant human p43(YS-1) on angiogenesis,and explore the antitumor activity of YS-1 in nude mice xenografted with lung adenocarcinoma A-549.Endothelial cell proliferation assay,cell migration assay,tube formation assay,rat aortic ring assay and chicken chorioallantoic membrane(CAM) assay were used to evaluate the anti-angiogenetic activity of YS-1,and Western blot analysis was used to investigate the related mechanism.A model of lung adenocarcinoma A-549 xenograft in nude mice was used to explore the antitumor efficacy of YS-1.It was found that YS-1 inhibited endothelial cell migration and tube formation,and YS-1 obviously inhibited microvessel sprouting from rat aortic rings and the vessel growth in CAM.In addition,YS-1 attenuated the activation of VEGFR2,MEK1/2 and Akt in response to vascular endothelial growth factor(VEGF).Moreover,high dose of YS-1(10 mg/kg) was shown to exert a remarkable antitumor effect in the examined model.Therefore,YS-1 can inhibit adenocarcinoma A-549 xenograft in nude mice and its mechanism may be related to the inhibition of angiogenesis resulting from the attenuation of activated VEGFR2 and downstream signaling molecules.
What problem does this paper attempt to address?